Cyclerion Therapeutics Stock Price

0.27 (8.71%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cyclerion Therapeutics Inc CYCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.27 8.71% 3.37 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.15 3.07 3.47 3.12 3.10
Bid Price Ask Price Spread News
3.30 3.37 0.07 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,472 932,264 $ 3.27 $ 3,049,910 - 2.08 - 8.96
Last Trade Time Type Quantity Stock Price Currency
19:04:14 formt 100 $ 3.37 USD


Draw Mode:

Cyclerion Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 145.84M 43.28M 35.86M $ 2.30M $ - -2.57 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.96M 6.30%

more financials information »

Cyclerion Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.093.48992.823.11498,5920.289.06%
1 Month2.733.48992.703.11289,1870.6423.44%
3 Months3.974.232.703.54565,981-0.60-15.11%
6 Months4.194.862.083.47911,982-0.82-19.57%
1 Year7.728.962.083.68768,085-4.35-56.35%
3 Years14.6419.891.694.15531,724-11.27-76.98%
5 Years14.6419.891.694.15531,724-11.27-76.98%

Cyclerion Therapeutics Description

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Your Recent History
Cyclerion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.